Skip to main content

Advertisement

Log in

The Neurocritical Care Research Network: NCRN

  • Review
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Neurocritical care diseases carry a high morbidity and mortality. Therapeutic and technological advances in neurocritical care have greatly improved the outcome of a variety of life-threatening disorders including traumatic brain injury, acute ischemic stroke, intracerebral and subarachnoid hemorrhage, and anoxic injury following cardiac arrest. These advances have stemmed from a better understanding of the physiology of neurocritical care illnesses, improved neuromonitoring techniques, and the introduction of more efficacious treatments. Despite all the advances in neuromonitoring, diagnostic imaging, and emerging treatments, much research needs to be undertaken in neurocritical care. Many of the clinical trials carried out in the general critical care population have excluded neurocritical care patients. For instance, the landmark ARDSNET trial that demonstrated the beneficial effects of low tidal volume ventilation in patients with ARDS cannot be directly applied to neurocritical care patients who frequently may experience this pulmonary complication. There is a need for a more cohesive and integrated research system or network to establish a track record for high-quality, investigator-initiated clinical research in neurocritical care. Such a system may help us overcome potential impediments to the future advancement of neurocritical care research. We propose the creation of the neurocritical care research network. The mission of the Network is to facilitate multicenter and multidisciplinary collaboration and patient enrollment in clinical trials of specific neurocritical care diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Smith M. Neurocritical care; has it come of age? B J Anaesthesia. 2004;93:753–5.

    Article  CAS  Google Scholar 

  2. Bleck T. Critical care and emergency neurology. In: Cohen MM, editor. The American academy of neurology: The first 50 years 1948–1998. St Paul: American Academy of Neurology; 1998. pp. 225–7.

  3. www.neurocriticalcare.org. Accessed 1 June 2010.

  4. Mayer SA, Coplin WM, Chang C, et al. Program requirements for fellowship training in neurological intensive care: United Council for Neurologic Subspecialties guidelines. Neurocritical Care. 2006;5:166–71.

    Article  PubMed  Google Scholar 

  5. Mayer SA, Coplin WM, Chang C, et al. Core curriculum and competencies for advanced training in neurological intensive care: United Council for Neurologic Subspecialties guidelines. Neurocritical Care. 2006;5:159–65.

    Article  PubMed  Google Scholar 

  6. www.ardsnet.org. Accessed 1 June 2010.

  7. www.anzics.com.au/ctg. Accessed 1 June 2010.

  8. www.ccctg.ca. Accessed 1 June 2010.

  9. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301–8.

    Article  Google Scholar 

  10. The National Heart, Lung, Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354:2564–75.

    Article  Google Scholar 

  11. The National Heart, Lung, Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354:1671–84.

    Article  Google Scholar 

  12. Cook DJ, Guyatt GH, Marshall J, et al., for the Canadian Critical Care Trials Group. A comparison of sucralfate and ranitidine for prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med. 1998;338:791–7.

    Google Scholar 

  13. Sandham JD, Hull RD, Brant RF, et al., for the Canadian Critical Care Trials Group. A randomised controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients N Engl J Med. 2003;38:5–14.

    Google Scholar 

  14. Cook DJ, Rocker G, Marshall J, et al., for the Level of Care Study Investigators and the Canadian Critical Care Trials Group. Withdrawal of mechanical ventilation in anticipation of death in the intensive care unit. N Engl J Med. 2003;349:1123–32.

    Google Scholar 

  15. Hutchison SJ, Ward RE, Lacroix J, et al., for the Hypothermia Pediatric Head Injury Trial investigators and the Canadian Critical Care Trials Group. Hypothermia Therapy Following Traumatic Brain Injury in Children. N Engl J Med. 2008;358:2447–56.

    Google Scholar 

  16. Bellomo R, Chapman M, Finfer S, et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. 2000;356:2139–43.

    Article  PubMed  CAS  Google Scholar 

  17. The SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247–56.

    Article  Google Scholar 

  18. The MERIT Study Investigators. Introduction of the medical emergency team (MET) system: a cluster-randomised controlled trial. Lancet. 2005;365:2091–7.

    Article  Google Scholar 

  19. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–7.

    Article  Google Scholar 

  20. Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346:557–63.

    Article  Google Scholar 

  21. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002;346:557–63.

    Article  PubMed  Google Scholar 

  22. Allen GS, Ahn HS, Preziosi TJ, et al. Cerebral arterial spasm—a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 1983;308:619–24.

    Article  PubMed  CAS  Google Scholar 

  23. Pickard JD, Murray GD, Illingwoth R, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ. 1989;298:636–42.

    Article  PubMed  CAS  Google Scholar 

  24. Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127–37.

    Article  PubMed  CAS  Google Scholar 

  25. Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the international surgical trial in intracerebral haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387–97.

    PubMed  Google Scholar 

  26. Muizelaar JP, Marmarou A, Ward JD, et al. Adverse effects of prolonged hyperventilation in patients with severe head injury: a randomized clinical trial. J Neurosurg. 1991;75:731–9.

    Article  PubMed  CAS  Google Scholar 

  27. http://www.nett.umich.edu/nett/welcome. Accessed 1 June 2010.

  28. Wright WL. Mapping neurocritical care units. Curr Neurocritical Care Soc Newslett. 2007;2(3):4.

    Google Scholar 

  29. http://www.hhs.gov/ohrp/humansubjects/guidance/hsdc97-01.htm. Accessed 1 June 2010.

  30. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=50.24. Accessed 8 June 2010.

  31. http://www.neurocriticalcare.org/i4a/pages/index.cfm?pageid=3961. Accessed 8 June 2010.

Download references

Acknowledgments

The First Neurocritical Care Research Conference was funded by award R13NS065494 from the National Institute of Neurological Disorders and Stroke (P.I.: JI Suarez), the Integra Foundation, and the Neuroscience Center of the St Luke’s Episcopal Hospital in Houston, TX, and endorsed by the Neurocritical Care Society.

Disclosures

The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke of the National Institutes of Health.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. I. Suarez.

Appendix

Appendix

The First Neurocritical Care Research Conference Investigators are listed below:

Organizing Committee Chair: Suarez JI, MD, Baylor College of Medicine, Houston, TX; Calvillo E, RN, Baylor College of Medicine, Houston, TX; Geocadin R, MD, Johns Hopkins University, Baltimore, MD; Hall C, MD, UT Southwestern University; Le Roux PD, MD, University of Pennsylvania, Philadelphia, PA; Livesay S, MS, RN, ACNP, St Luke’s Episcopal Hospital, Houston, TX; Mayer SA, MD, Columbia University, New York, NY; Vespa P, MD, UCLA, Los Angeles, CA; Wijman C, MD, Stanford University, Palo Alto, CA; Zaidat OO, MD, MS, Medical College of Wisconsin, Milwaukee, WI.

Speakers Bleck TP, RUSH School of Medicine, Chicago, IL; Chang C, MD, University of Hawaii, John A. Burns School of Medicine, Honolulu, HI; Cooper DJ, MD, Alfred Hospital and Monash University, Melbourne, Australia;

Guntupalli KK, MD, Baylor College of Medicine, Houston, TX; Daily J, PhD, Case Western Reserve University, Cleveland, OH; Diringer MA, MD, Washington University School of Medicine, St Louis, MO; Robertson CS, MD, Baylor College of Medicine, Houston, TX; Hanley DF, MD, Johns Hopkins University, Baltimore, MD;

Hemphill C III, MD, PhD, University of California in San Francisco, San Francisco, CA; Koroshetz W, MD, Deputy Director, NINDS, Bethesda. MD;

Mirski MA, MD, PhD, Johns Hopkins University, Baltimore, MD; Palesch Y, PhD, Medical University of South Carolina; Qureshi AI, MD, University of Minnesota, Minneapolis, MN; Silbergleit R, MD, University of Michigan, Ann Arbor, MI;

Smirnakis SM, MD, PhD, Baylor College of Medicine, Houston, TX; Szigeti K, MD, PhD, Baylor College of Medicine, Houston, TX.

Attendees Adeoye O, MD, University of Cincinnati College of Medicine, Cincinnati, OH; Aisiku IP, University of Texas in Houston, Houston, TX; Bader MK, RN, Mission Viejo Hospital, Mission Viejo, CA; Ansari S, MD, Baylor College of Medicine, Houston, TX; Arshad ST, MD, Baylor College of Medicine, Houston, TX; Badjatia N, MD, Columbia University, New York, NY; Barazangi N, MD, Ph.D., Califorrnia Pacific Medical Center, San Francisco, CA; Bershad EM, MD, Baylor College of Medicine, Houston, TX; Boyd C, RN, MBA, St Luke’s Episcopal Hospital, Houston, TX; Claassen J, MD, Columbia University, New York, NY; Coplin W, MD, Wayne State University, Detroit, MI; Corry JJ, Henry Ford Hospital, Detroit, MI; Cruz-Florez S, MD, St Louis University, St Louis, MO; Dhar R, MD, Washington University School of Medicine, St Louis, MO; Dillon C, MS, Medical University of South Carolina, Charleston, SC; Divani AA, Ph.D., University of Minnesota, Minneapolis, MN; Duckworth E, MD, Baylor College of Medicine, Houston, TX; Ezzedine M, MD, University of Minnesota, Minneapolis, MN; Feen E, MD, St Louis University, St Louis, MO; Freeman W, MD, Mayo Clinic Florida, Jacksonville, FL; Frontera J, MD, Mount Sinai School of Medicine, New York, NY; Goodman JC, MD, Baylor College of Medicine, Houston, TX; Graffagnino C, MD, Duke University, Durham, NC; Hoesch RE, MD, PhD, Johns Hopkins University, Baltimore, MD; Ko NU, MD, University of California in San Francisco, San Francisco, CA; Koening M, MD, Johns Hopkins University, Baltimore, MD; Kramer A, University of Calgary, Calgary, AL, Canada; Lazaridis C, MD, Medical University of South Carolina, Charleston, SC; Lee JC, MD, Baylor College of Medicine, Houston, TX; Ling G, MD, PhD, US Armed Forces, Bethesda, MD; Macdonald RL, MD, Ph.D., University of Toronto, Toronto, ON, Canada; Malkoff M, MD, University of New Mexico, Albuquerque, NM; Mandava P, MD, Baylor College of Medicine, Houston, TX; Manno E, MD, Mayo Clinic, Rochester, MN; Martin H Renee, Ph.D., Medical University of South Carolina, Charleston, SC; Mawad M, MD, Baylor College of Medicine, Houston, TX; Mizrahi E, MD, Baylor College of Medicine, Houston, TX; McArthur DL, Ph.D., UCLA, Los Angeles, CA; Nathan B, MD, University of Virginia, Charlottesville, VA; Newmark M, MD, Baylor College of Medicine, Houston, TX; Nguyen T, PharmD, St Luke’s Episcopal Hospital, Houston, TX; Nyquist P, MD, Ph.D., The Johns Hopkins Hospital, Baltimore, MD; Oliveira J, Hospital San Rafael, Universidade Federale da Bahia, Salvador, Brazil; Olson DW, RN, PhD, Duke University, Durham, NC; Ougorets I, MD, New York Weil Medical College of Cornell University, New York, NY; Puppo C, MD, Universidad de la República, Montevideo, Uruguay; Pyne-Geithman G, Ph.D., University of Cincinnati, Cincinnati, OH; Rao CPV, Baylor College of Medicine, Houston, TX; Revuelto J, MD, Hospital Virgen del Rocio, Seville, Spain Rhoney D, PharmD, Detroit Receiving Hospital, Detroit, MI; Riviello J, MD, Baylor College of Medicine, Houston, TX; Sawaya R, MD, Baylor College of Medicine, Houston, TX; Seder D,MD, Maine Medical Center, Portland, ME; Sheth K, MD, Brigham and Women’s Hospital, Boston, MA; Souter M, MD, University of Washington, Seattle, WA; Strutt AM, Ph.D., Baylor College of Medicine, Houston, TX; Suri MFK, MD, University of Minnesota, Minneapolis, MN; Temes R, MD, RUSH Medical Center, Chicago, IL; Torbey MT, MD, MPH, Medical College of Wisconsin, Milwaukee, WI; Treggiari M, University of Washington, Seattle, WA; Urfy MZ, MD, Baylor College of Medicine, Houston, TX Varelas P, MD, Ph.D., Henry Ford Hospital, Detroit, MI; Wright W, MD, Emory University, Atlanta, GA; York MK, Ph.D., Baylor College of Medicine, Houston, TX; Ziai W, MD, Johns Hopkins University, Baltimore, MD; Zwillman M, MD, The Methodist Hospital, Houston, TX.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Suarez, J.I., Geocadin, R., Hall, C. et al. The Neurocritical Care Research Network: NCRN. Neurocrit Care 16, 29–34 (2012). https://doi.org/10.1007/s12028-011-9612-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-011-9612-x

Keywords

Navigation